CSE: MMEN

In recent months, MedMen Enterprises Inc. (CSE: MMEN), has been a hot topic in the press due to their growing enterprise, and the surge of interest in legal cannabis. The company's aggressive public relations campaigns, as well as its aggressive investments in their product lines, are making it the talk of the marijuana industry in the U.S., as well as in Canada. The company's growing legal and business presence can be attributed to two key strategies: the use of media and its investments in its own public relations program.

Media coverage of the company has included interviews with key industry players such as John Hendricks, who has served on the advisory board for MedMen Enterprises, and is now the CEO of the company; Michael Allison, a former reporter for the Washington Post that specializes in cannabis and marijuana law issues; and David Downs, a reporter for High Times. These media outlets have reported on the company's recent success and are beginning to reflect more positively on it than they have in years past. In addition to these media appearances, the company has also invested heavily in its own media and public relations campaign and are investing heavily in new media and public relations programs as well. This aggressive PR campaign were led by Paul Lewis, who was formerly the president of the Associated Press. Lewis spent many years at AP, working his way up from managing reporter to president of AP. In addition to this impressive background in the news industry, Lewis has also been an outspoken advocate for legalized marijuana. He co-founded an organization called the Marijuana Policy Project, which is an organization focused on bringing marijuana legalization initiatives to state ballot measures.

MedMen has invested millions of dollars in public relations and media efforts, and according to the MMJ Industry News Web site, "In the coming months, MedMen intends to expand its business activities into new markets in North Carolina, Maryland, and Colorado as well as a joint venture with private equity firm Silverton Partners."

*This article is intended to be used for informational purposes only. Please consult your financial advisor for personal financial advice related to any organizations mentioned in our articles*